The US Food and Drug Administration would need to establish two new intercenter institutes or “Centers of Excellence” if Congress clears the new Cures 2.0 legislation. But without any new funding to do it, the plan could frustrate the agency, which has run into budgetary challenges with its first such intercenter institute the Oncology Center of Excellence.
The draft Cures 2.0 legislation requires the two centers to be established within a year of the bill’s enactment or...






